Use of estrogens for the prevention and treatment of Alzheimer's disease

Dementia and Geriatric Cognitive Disorders

Volumn 11, Issue 1, 2000, Pages 1-10

  Monk, Dorota ^a   Brodaty, Henry ^a,b  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Alzheimer's disease; Central nervous system; Cognition; Dementia; Estrogens; Prevention; Treatment

Indexed keywords

ACETYLCHOLINE; AMYLOID BETA PROTEIN; ANTIDEPRESSANT AGENT; ANTIOXIDANT; COUMESTROL; ESTRADIOL; ESTROGEN; ISOFLAVONE; LACTONE DERIVATIVE; LIGNAN; NEUROMODULIN; NEUROTRANSMITTER; NEUROTROPHIN; PHYTOESTROGEN; PROGESTERONE; TACRINE;

AFFECTIVE NEUROSIS; ALZHEIMER DISEASE; BRAIN BLOOD FLOW; BREAST CANCER; CHOLINERGIC SYSTEM; COGNITION; COGNITIVE DEFECT; CONCENTRATION LOSS; DEMENTIA; DEPRESSION; DRUG EFFICACY; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; ESTROGEN THERAPY; FEMALE; GLUCOSE METABOLISM; HUMAN; NERVE GROWTH; POSTMENOPAUSE; PRIORITY JOURNAL; REVIEW; SYNAPSE; UTERUS BLEEDING; WHITE MATTER;

EID: 0033964987     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000017206     Document Type: Review

References (87)

1. American Psychiatric Association: Practice guideline for the treatment of patients with Alzheimer's disease and other dementias of late life. Am J Psychiatry 1997;157(suppl):1-39.
2. Marx J: Searching for drugs that combat Alzheimer's disease. Science 1996;273:50-53.
3. Lautenschlager NT, Cupples LA, Rao VS, Auerbach SA, Becker R, Burke J, Chui H, Duara R, Foley EJ, Glatt SL, Green RC, Jones R, Karlinsky H, Kukull WA, Kurz A, Larson EB, Martelli K, Sadovnick AD, Volicer L, Waring SC, Growdon JH, Farrer LA: Risk of dementia among relatives of Alzheimer's disease patients in the MIRAGE study: What is in store for the oldest old? Neurology 1996;46:641-650.
4. Luine VN: Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp Neurol 1985;89:484-490.
5. Singh M, Meyer EM, Millard WJ, Simpkins JW: Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats. Brain Res 1994;644:305-312.
6. Arenander AT, De Vellis J: Development of the nervous system; in Siegel G (ed): Basic Neurochemistry: Molecular. Cellular and Medical Aspects, ed 5. New York, Raven Press, 1994, pp 584-586.
7. McMillan P, Singer C, Dorsa D: The effects of ovariectomy and estrogen replacement on trkA and choline acetyltransferase mRNA expression in the basal forebrain of the adult female Sprague-Dawley rat. J Neurosci 1996;16:1860-1866.
8. Kordower JH, Winn SR, Liu YT, Mufson EJ, Sladek JR, Hammang JP, Baetge EE, Emerich DF: The aged monkey basal forebrain: Rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human growth factor. Proc Natl Acad Sci USA 1994;91:10898-10902.
9. Ferreira A, Cacares A: Estrogen-enhanced neurite growth and tau proteins. J Neurosci 1991; 11:397.
10. Toran-Allerand C, Miranda R, Bentham W, Sohrabji F, Brown T, Hochberg R, MacLusky N: Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Neurobiology 1992;89:4668-4672.
11. Mudd LM, Torres J, Lopez TF, Montague J: Effects of growth factors and estrogen on the development of septal cholincrgic neurons from the rat. Brain Res Bull 1998;45:137-142.
12. Singh M, Meyer E, Simpkins J: The effects of ovariectomy and estradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of female Sprague-Dawley rats. Endocrinology 1995;136:2320-2324.
13. Schughrue P, Dorsa M: Estrogen modulates the growth-associated protein GAP-43 (neuromodulin) mRNA in the rat preoptic area and basal hypothalamus. Neuroendocrinology 1993;57: 439-447.
14. Manning C, Ragozzino M, Gold P: Glucose enhancement of memory in patients with probable senile dementia of the Alzheimer's type. Neurobiol Aging 1993;14:523-528.
15. Bishop J, Simpkins J: Estradiol enhances brain glucose uptake in ovariectomized rats. Brain Res Bull 1995;36:315-320.
16. Keller JN, Germeyer A, Begley JG, Mattson MP: 17β-Estradiol attenuates oxidative impairment of synaptic Na/K-ATPase activity, glucose transport and glutamate transport induced by amyloid β-peptide and iron. J Neurosci Res 1997;50:522-530.
17. Eberling JL, Jagust WJ, Reed BR, Baker MG: Reduced temporal lobe blood flow in Alzheimer's disease. Neurobiol Aging 1992;13:483-491.
18. Okhura T, Isse K, Akazawa K, Hamamoto M, Yaoi Y, Hagino N: Evaluation of estrogen treatment in female patients with dementia of the Alzheimer's type. Endocr J 1994;41:361-371.
19. Mukai K, Daifuku K, Yokoyama S, Nakano M: Stopped-flow investigation of antioxidant activity of estrogens in solution. Biochim Biophys Acta 1990;1035:348-352.
20. Venters H, Bonilla L, Jensen T, Garner H, Bordayo E, Najarian M, Ala T, Mason R, Frey W: Heme from Alzheimer's brain inhibits muscarinic receptor binding via thiyl radical generation. Brain Res 1997;764:93-100.
21. Behl C, Davis B, Lesley R, Schubert D: Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 1994;77:817-827.
22. Behl C, Widmann M, Trapp T, Holsboer F: 17-Beta-estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem Biophys Res Commun 1995;216:473-482.
23. Jaffe AB, Toran-Allerand CD, Greengard P, Gandy SE: Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein. J Biol Chem 1994;269:13065-13068.
24. Hashimoto S, Katou M, Dong Y, Murakami K, Terada S, Masaki I: Effects of hormone replacement therapy on serum amyloid P component in postmenopausal women. Maturitas 1997;26:113-119.
25. Chung SK, Pfaff DW, Cohen RS: Estrogen-induced alterations in synaptic morphology in the midbrain central gray. Exp Brain Res 1988; 69:522-530.
26. Wooley CS, McEwen BS: Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat. J Neurosci 1992;12:2549-2554.
27. Wooley CS, McEwen BS: Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat. J Comp Neurol 1993;336:293-306.
28. Weiland N: Estradiol selectively regulates agonist binding sites on the N-methyl-D-aspartate receptor complex in the CA1 region of the hippocampus. Endocrinology 1992;131:662-668.
29. Wooley CS, Weiland NG, McEwen BC, Schwartzkroin PA: Estradiol increases sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated synaptic input: Correlation with dendritic spine density. J Neurosci 1997;17:1848-1859.
30. Naftolin F, Lerenth C, Garcia-Segura LM: Estrogen induces synaptic plasticity in adult primate neurons. Neuroendocrinology 1993;57: 935-939.
31. Roy E, Buyer D, Licari V: Estradiol in the striatum: Effects on behaviour and dopamine receptors hut no evidence for membrane steroid receptors. Brain Res Bull 1990;25:221-227.
32. Thompson T, Moss R: Estrogen regulation of dopamine release in the nucleus accumbens: Genomic and nongenomic-mediated effects. J Neurochem 1994;62:1750-1756.
33. Fink G, Sumner B, Rosie R, Grace O, Quinn J: Estrogen control of central neurotransmission: effect on mood, mental state, and memory. Cell Mol Neurobiol 1996;16:325.
34. Gonzales GF, Carillo C: Blood serotonin levels in postmenopausal women: Effects of age and scrum oestradiol levels. Maturitas 1993;17:23-29.
35. Pearlstein T, Rosen K, Stone A: Mood disorders and menopause. Endocrinol Metab Clin North Am 1997;2:279-288.
36. Pantoni L, Garcia J: Cognitive impairment and cellular/vascular changes in the cerebral white matter. Ann NY Acad Sci 1997;826:92-102.
37. Schmidt R, Fazekas F, Reinhart B, Kapeller P, Fazekas G, Offenbacher H, Eber B, Schumacher M, Freidl W: Estrogen replacement therapy in older women: A neuropsychological and brain MRI study. J Am Geriatr Soc 1996;44: 1307-1313.
38. O'Neal MF, Means LW, Poole MC, Hamm RJ: Estrogen affects performance of ovariectomized rats in a two-choice water-escape working memory task. Psychoneuroendocrinology 1996;21:51-56.
39. Szklo M, Cerhan J, Diez-Roux A, Chambless L, Cooper L, Folsom AR, Fried LP, Knopman D, Nieto J: Estrogen replacement therapy and cognitive functioning in the atherosclerosis risk in communities (ARIC) study. Am J Epidemiol 1996;144:1048-1057.
40. Henderson VW, Watt L, Buckwalter J: Cognitive skills associated with estrogen replacement in women with Alzheimer's disease. Psychoneuroendocrinology 1996;21:421-430.
41. Kempen DL, Scherwin BB: Estrogen use and verbal memory in healthy postmenopausal women. Obstet Gynecol 1994;83:979-983.
42. Barret-Connor E, Kritz-Silverstein D: Estrogen replacement therapy and cognitive function in older women. JAMA 1993;269:2637-2641.
43. Paganini-Hill A, Henderson V: The effects of hormone replacement therapy, lipoprotein cholesterol levels, and other factors on a clock-drawing task in older women. J Am Geriatr Soc 1996;55:818-822.
44. Philips SM, Sherwin BB: Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 1992;17: 485-495.
45. Ditkoff E, Crary W, Cristo M, Lobo R: Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol 1991;78:991.
46. Brenner DE, Kukull WA, Stergachis A, van Belle G, Bowen JD, McCormick WC, Teri L, Larson EB: Postmenopausal estrogen replacement therapy and the risk of Azlheimer's disease: A population-based case-control study. Am J Epidemiol 1994;140:262-267.
47. Paganini-Hill A, Henderson VW: Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol 1994;140:256-261.
48. Paganini-Hill A, Henderson V: Estrogen replacement therapy and risk of Alzheimer's disease. Arch Intern Med 1996;156:2213-2217.
49. Mortel K, Meyer J: Lack of postmenopausal estrogen replacement therapy and the risk of dementia. J Neuropsychiatry Clin Neurosci 1995;7:334-337.
50. Henderson VW, Paganini-Hill A, Emanuel CK, Dunn ME, Buckwalter J: Estrogcn replacement therapy in older women. Arch Neurol 1994;51:896-900.
51. Tang M, Jacobs D, Yaakow S, Marder K, Schofield P, Andrews H, Mayeux R: Effects of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996;348: 429-432.
52. Kawas C, Resnick S, Morrison A, Brookmeyer R, Corrada M, Zonderman A, Bacal C, Donnel Lingle D, Melter E: A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease. Neurology 1997;48:1515-1521.
53. Baldereschi M, Di Carlo A, Lepore V, Bracco L, Maggi S, Grigoletto F, Scarlato G, Amaducci L: Estrogen-replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging. Neurology 1998;50:996-1002.
54. Honjo H, Ogino Y, Naitoh K, Urahe M, Kitawaki J, Yasuda J, Yamamoto T, Ishihara S, Okada H, Yonezawa T, Hayashi K, Nambara T: In vivo effects by estrone sulfate on the central nervous system-senile dementia (Alzheimer's type). J Steroid Biochem 1989;34:521-525.
55. Fillit H, Weinreb H, Cholst I, Luine V, McEwen B, Amador R, Zabriskie J: Observations in a preliminary open trial of oestradiol therapy for senile dementia Alzheimer's type. Psychoneuroendocrinology 1986;11:337.
56. Okhura T, Isse K, Akazawa K, Yaoi Y, Hagino N: Long-term estrogen replacement therapy in female patients with dementia of the Alzheimer's type: Seven case reports. Dementia 1995; 6:99-101.
57. Schneider LS, Farlow MR, Henderson VW, Pogoda JM: Effects of estrogen replacement therapy on response to tacrine in patiens with Alzheimer's disease. Neurology 1996;46:1580-1584.
58. Doraiswamy PM, Bieber F, Kaiser L, Krishan KR, Reuning-Scherer J, Gulanski B: The Alzheimer's disease assessment scale: Patterns and predictors of baseline cognitive performance in multicenter Alzheimer's disease trial. Neurology 1997;48:1511-1517.
59. Rosen WG, Mohs RC, Davies KL: A new rating scale for Alzheimer's disease. Am J Psychiatry 1984;141:1356-1364.
60. Lendon CL, Ashall F, Goate AM: Exploring the etiology of Alzheimer's disease using molecular genetics. JAMA 1997;277:825-831.
61. Halbreich U: Role of estrogen in postmenopausal depression. Neurology 1997;48(suppl 7):16-20.
62. Pearce J, Hawton K, Blake F: Psychological and sexual symptoms associated with the menopause and the effects of hormone replacement therapy. Br J Psychiatry 1995;167:163-173.
63. Dennerstein L, Burrows G, Hyman G, et al: Hormone therapy and affect. Maturitas 1979; 1:247-259.
64. Nathorst-Boos J, von Schoultz B, Carlstrom K: Elective ovarian removal and estrogen replacement therapy - Effects on sexual life, psychological well-being and androgen status. J Psychosom Obstet Gynecol 1993;14:283-293.
65. Sherwin B, Gelfand M: Sex steroids and affect in surgical menopause: A double-blind, crossover study. Psychoneuroendocrinology 1985; 10:325-335.
66. Fedor-Freybergh P: The influence of oestrogens on the well-being and mental performance in climacteric and postmenopausal women. Acta Obstet Gynecol Scand 1977 suppl 64:1-91.
67. Furuhjelm M, Karlgren E, Carlstrom K: The effect of estrogen therapy on somatic and psychical symptoms in postmenopausal women. Acta Obstet Gynecol Scand 1984;63:655-661.
68. Sherwin BB, Gelfand MM: A prospective oneyear study of estrogen and progestin in postmenopausal women: Effects on clinical symptoms and lipoprotein lipids. Obstet Gynecol 1989;73:759-766.
69. Derman RJ, Dawood MY, Stone S: Quality of life during sequential hormone replacement therapy: A placebo-controlled study. Int J Fertil 1995;40:73-78.
70. Purdic DW, Empson JAC, Crichton C, et al: Hormone replacement therapy, sleep quality and psychological well-being. Br J Obstet Gynaecol 1995;102:735-739.
71. Chatel A, Fugere P, Bissonnette F, et al: Psychological distress and sexuality in a group of women attending a menopause clinic: Effect of hormonal replacement therapy. Menopause 1996;3:165-171.
72. Campbell S, Whitehead M: Oestrogen therapy and the menopausal syndrome. Clin Obstet Gynecol 1977;4:31-47.
73. Schiff I, Regestein Q, Tulchinski D, et al: Effects of estrogens on sleep and psychological state of hypogonadal women. JAMA 1979;242: 2405-2407.
74. Iatrakis G, Haronis N, Sakellaropoulos G, et al: Psychosomatic symptoms of postmenopausal women with or without hormonal treatment. Psychother Psychosom 1986;46:116-121.
75. Myers LS, Dixen J, Morrissette D, et al: Effects of estrogen, androgen, and progestin on sexual psychophysiology and behaviour in postmenopausal women. J Clin Endocrinol Metab 1990; 70:1124-1131.
76. Schneider MA, Brotherton PL, Heiles J: The effects of exogenous oestrogens on depression in menopausal women. Med J Aus 1977;ii: 162-165.
77. Holsboer F, Benkert O, Dcmish L: Changes in MAO activity during estrogen treatment of females with endogenous depression. Mod Probl Pharmacopsychiatry 1983;19:321-326.
78. Maoz B, Shiber A, Lazer S, et al: The prevalence of psychological distress among postmenopausal women attending a menopausal clinic and the effect of hormone replacement therapy on their mental state. Menopause 1994;1:137-141.
79. Murkies A, Wilcox G: A GP's guide to phytoestrogens. Mod Med Aust 1998;41:26-31.
80. Murkis A, Lombard C, Strauss B: Dietary fluor supplementation decreases postmenopausal hot flushes: Effect of soy and wheat. Maturitas 1995;21:189-195.
81. Hammond CB: Menopause and hormone replacement therapy: An overview. Obstet Gynecol 1996;87:2S-15S.
82. Chute CG, Willet WC, Colditz GA, et al: A prospective study of reproductive history and exogenous estrogens on the risk of colorectal cancer in women. Epidemiology 1991;2:201-207.
83. Mahcox R, Naud F, Riox M, Grenier R, Lemay A, Guy J, Langevin M: A randomised, double-blind, placebo-controlled study on the effect of conjugated estrogen on skin thickness. Am J Obstet Gynecol 1994;170:642-649.
84. Llewellyn-Jones D: Fundamentals of Obstetrics and Gynaecology, ed 6. St Louis, Mosby. 1994.
85. Speroff L: Postmenopausal hormone therapy and breast cancer. Obstet Gynecol 1996;87: 44S-54S.
86. Skolnick A: Evaluating estrogen for Alzheimer's disease poses ethical and logistical challenges. JAMA 1997;277:1832-1833.
87. Brodaty H, Sachdev P: Drugs for prevention and treatment of Alzhemer's disease. Me J Aust 1997;67:447-452.